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ABSTRACT
An increasing number of infections caused by community-associated methicillin-resistant Staphylococcus
aureus (CA-MRSA) carrying the Panton–Valentine leukocidin (PVL) genes was recently identiﬁed in
Greece. In the present study, 170 patients with S. aureus infections and 123 uninfected children
(<15 years old) who had been tested for nasal carriage were evaluated during a 2-year period. The
MecA, PVL and superantigen family genes, and MRSA clones, were investigated by molecular methods.
Sites of infection and laboratory ﬁndings for patients were recorded. The results were compared and
statistically analysed. Among 123 uninfected children 73 (59%) carried S. aureus, including four MRSA
strains. Of these, three MRSA and three methicillin-sensitive S. aureus (MSSA) strains were PVL-positive
(p <0.0001). Ninety-six patients (96 ⁄ 170) exhibited skin and soft-tissue infections (SSTIs), and 74
exhibited invasive infections. The incidence of staphylococcal infections increased during July to
September each year. In total, 110 S. aureus isolates were PVL-positive (81 from SSTIs and 29 from
invasive infections, p <0.0001). Ninety-nine out of 106 MRSA (93%) isolates from 170 patients carried
the PVL genes (p <0.0001); 97 belonged to the clonal complex CC80. Leukocytes and polymorphonuclear
cell counts were higher among children with MRSA infections (p <0.005). MSSA predominated among
patients with invasive infections (43 ⁄ 74), and carried mainly genes of the superantigen family. Children
<5 years of age showed a higher risk of MRSA infection. The present study demonstrates that infections
due to PVL-positive CA-MRSA spread easily among children, and SSTIs can lead to invasive infections.
Nasal colonization may be an additional factor contributing to the emergence of CA-MRSA.
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INTRODUCTION
Staphylococcus aureus is the most frequent cause of
skin and soft-tissue infections (SSTIs), as well as
invasive infections, in adults and children [1].
Infections due to methicillin-resistant S. aureus
(MRSA) in the absence of predisposing risk
factors have been documented in the community,
and referred to as community-associated MRSA
(CA-MRSA) infections [2,3]. Reports have shown
an increasing incidence of MRSA infections
among children worldwide, including SSTIs, bac-
teraemias, and musculoskeletal infections [4–7].
Prevention of staphylococcal infections and
reduction of the spread of CA-MRSA are of great
importance. The association between S. aureus
nasal carriage and infections has been established
by identifying strains with the same genotype [8].
Genetic variations of strains reﬂect corresponding
clinical manifestations. CA-MRSA isolates carry
smaller staphylococcal cassette chromosome
(SCCmec) elements (IV and V) than do hospital-
associated strains, and therefore express a phe-
notype of greater antibiotic susceptibility [2,9,10].
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In the majority of CA-MRSA isolates, the presence
of the lukS-PV and lukF-PV genes encoding
Panton–Valentine leukocidin (PVL), a pore-form-
ing exotoxin, has been documented [2,9,11]. These
strains usually cause SSTIs and necrotizing pneu-
monia [2,3,11–13].
The spread of infections caused by PVL-
positive CA-MRSA in Greece is remarkable,
similar to that in the USA [3,11,13,14]. Such
strains are distributed in the community and
hospital settings, and cause acute osteomyelitis
among children [11,15].
In this report, CA-MRSA infections among
children during a 2-year period are described. In
parallel, S. aureus nasal carriage was investigated,
and the molecular characteristics of the isolated
strains were set in relation to clinical and labora-
tory ﬁndings.
MATERIALS AND METHODS
Description of studied cases
In the present study, 170 children (<15 years of age) with
S. aureus infections proved by culture and available clinical and
laboratory data (52% of total S. aureus infections) during a
2-year period (2005–2006) were evaluated. Patients were admit-
ted to the Department of Paediatrics of the University Hospital
(95 patients) and Karamandaneion Children’s Hospital (75
patients) located in Patras, to which all children from western
Greece are referred. These institutions have 65 and 90 paediatric
beds, respectively, and receive c. 59 000 ambulatory visits and
9000 child admissions per year, covering an area of 1 200 000
inhabitants, roughly 12% of the total population of Greece.
White blood cell (WBC) counts, polymorphonuclear neu-
trophil (PMN) counts, erythrocyte sedimentation rates and C-
reactive protein (CRP) were determined in the studied patients
upon admission. Depending on the site, cultures were per-
formed for all children with suspected ongoing infection
accordingly. Invasive infections included osteomyelitis, septic
arthritis, deep-seated wound infections, lymphadenitis, otitis,
pyomyositis, deep abscesses involving organs and structures
other than skin and subcutaneous tissues, urinary tract
infections, pneumonia, and bactaeremia; SSTIs included cellu-
litis, pyodermia, superﬁcial wound infections, boils, conjunc-
tivitis, paronychia, impetigo and neonatal omphalitis. A case
was considered as community-associated or hospital-associ-
ated according to CDC deﬁnitions [16]. The presence of known
risk factors for MRSA was assessed from a questionnaire
completed by the child’s accompanying care-giver.
In parallel, S. aureus nasal carriage was investigated among
123 healthy uninfected children of similar gender and age
attending primary-care outpatients’ facilities for a regular
checkup (with permission of the accompanying care-giver).
Nasal swabs from both anterior nares were placed in Stuart
transport medium, inoculated into Tryptic Soy Broth (TSB,
BBL, Becton Dickinson, Le Pont de Claix, France) and
incubated at 37C for 18 h. Samples were subcultured onto
mannitol–salt agar (BBL, Becton Dickinson) and further
incubated at 37C for 48 h [17]. Yellow colonies were tested
for coagulase production by the Slidex Staph Plus agglutina-
tion test (bioMe´rieux, RCS Lyon, France) and other standard
methods [18].
Phenotypes of bacterial isolates
S. aureus isolates originated from different patients with signs
of infection (one isolate per patient). Antibiotic susceptibility
testing was performed by the disk diffusion method with
cefoxitin, vancomycin, kanamycin, gentamicin, tobramycin,
netilmicin, erythromycin, clindamycin, ciproﬂoxacin, sulpha-
methoxazole–trimethoprim, linezolid and fusidic acid (BBL,
Becton Dickinson) [19,20]. b-Lactamase production was tested
in all isolates (including those from uninfected children) with
nitroceﬁn disks (BBL, Becton Dickinson), and inducible resis-
tance to clindamycin with the D-test [19]. The MIC of oxacillin
was determined with the Etest (AB Biodisk, Solna, Sweden)
[21].
Molecular typing
The presence of the mecA gene encoding resistance to meth-
icillin, and the identity of the PVL genes lukS-PV and lukF-PV,
of tst (encoding toxic shock syndrome toxin-1), eta and etb
(encoding exfoliative toxins A and B) and of seg and sem of the
enterotoxin gene cluster, were studied using PCR with speciﬁc
primers [9,10,22,23]. MRSA clones were deﬁned on the basis of
pulsed-ﬁeld gel electrophoresis (PFGE) patterns of SmaI-
digested DNA [11,24] and agr typing [25]. Representative
strains based on PFGE ⁄ agr type and toxin gene proﬁle were
selected, further characterized by multilocus sequence typing
[24,26] and compared to previously identiﬁed clones [11,13,15].
Methicillin-sensitive S. aureus (MSSA) clones were identiﬁed
by PFGE of SmaI DNA digests.
Statistical analysis
Statistical analyses were conducted using the SPSS v.12.0
software package for Windows (SPSS Inc., Chicago, IL, USA).
Categorical data were expressed as percentages and quantita-
tive data as mean value (± standard deviation or ± standard
error of the mean). Age was expressed as median (intraquartile
range (IQR)) because values were skewed. Patients were
stratiﬁed into two age groups, younger or older than
60 months. Differences between groups were calculated by
the unpaired t-test or Mann–Whitney U-test (non-parametric)
as appropriate for quantitative data, and the chi-squared test
was used for categorical data. In addition, ORs and 95% CIs
were calculated. A probability value <0.05 was considered to
be signiﬁcant.
RESULTS
Characteristics of patients
The increased incidence of S. aureus infections
accounted for the majority of admissions in both
the Department of Paediatrics of the University
Hospital and the Karamandaneion Children’s
Hospital during recent years. More speciﬁcally,
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the percentages of S. aureus infections among the
total number of hospitalized children were 0.9%
in 2004, 1.03% in 2005, and 1.4% in 2006,
respectively. The total numbers of patients with
MRSA among all those with S. aureus infections,
including patients from both institutions, were
96 ⁄ 181 (53%) in 2005 and 126 ⁄ 178 (71%) in 2006.
Community-onset MRSA infections were attrib-
uted to 62% of the studied cases (105 ⁄ 170),
whereas, only one MRSA case was hospital-
associated. The monthly distribution of both
MRSA-infected and MSSA-infected children, as
well as the cases studied during 2005 and 2006,
are shown in Fig. 1. There was a distinct seasonal
distribution of staphylococcal infections, which
occurred mainly between July and September
during both years of the study. Among the 170
studied patients (90 in 2005 and 80 in 2006), 114
were hospitalized. All S. aureus infections were
community-associated, except for one case, where
the patient had been previously hospitalized. The
median age of patients included in the study was
30 months (IQR 10.5–83.5), involving 99 boys and
71 girls. Seventy-four patients (74) had invasive
infections, including osteomyelitis (20), septic
arthritis (15), deep-seated wound infection (10),
otitis (nine), lymphadenitis (four), pyomyositis
(four), pneumonia (four), deep abscesses (three),
bacteraemia (three) and urinary tract infections
(two).
Ninety-six patients had SSTIs, including cellu-
litis (25), pyodermia (23), superﬁcial wound
infections (18), boils (eight), conjunctivitis (eight),
paronychia (six), impetigo (ﬁve) and neonatal
omphalitis (three). Laboratory blood examination
of patients with invasive infections, when com-
pared to SSTIs, revealed that only CRP values
(mean value ± standard error of the mean) were
statistically signiﬁcant (4.0 ± 0.74 vs. 2.0 ± 0.32,
p 0.0071).
Whereas the median age of MRSA-infected
children was 30 months (IQR 15–60 months),
that of the MSSA-infected group was 27 months
(IQR 5–96 months, p 0.61). The incidence of
MRSA infections in children younger than
60 months was 72%, and among older patients
it was 52% (p 0.027; OR = 2.26; 95% CI = 1.09–
4.71). The majority of MRSA infections (75 ⁄ 106 or
71%) were SSTIs, whereas MSSA predominated
in invasive infections (43 ⁄ 64, 67%) (Table 1). A
statistically signiﬁcant difference was calculated
for WBC and PMN counts among MRSA-infected
patients as compared to the MSSA-infected group
(Table 1). The differences in erythrocyte sedimen-
tation rates and CRP levels were not statistically
signiﬁcant (p >0.05).
Characteristics of S. aureus strains
MRSA isolates were classiﬁed into four clones
according to their PFGE ⁄ agr and MLST types
(Table 2). The majority of PVL-positive isolates
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Fig. 1. Monthly distribution of the
total number of admitted children
with Staphylococcus aureus infections
(IP: infected patients, methicillin-
resistant S. aureus (MRSA) and
methicillin-sensitive S. aureus (MSSA))
in both institutions and the studied
cases (SC) during 2005 and 2006.
Table 1. Clinical and laboratory ﬁndings for the 170
studied patients with Staphylococcus aureus infections
Patients with
MRSA infection
(n = 106)
Patients with
MSSA infection
(n = 64) p-value
Deep-seated infections (%) 31 (29%) 43 (67%) <0.0001a
SSTIs (%) 75 (71%) 21 (33%) <0.0001a
WBC count (mean ± SD) 14534 ± 5478 11430 ± 3881 0.0017b
PMN count (mean ± SD) 8453 ± 4553 6055 ± 3541 0.0042b
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus; SD,
standard deviation; SSTIs, skin and soft-tissue infections; WBC, white blood cell;
PMN, polymorphonuclear neutrophil.
aChi-squared test.
bUnpaired t-test.
Sdougkos et al. Staphylococcus aureus infections among children 997
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 995–1001
(97) and three additional PVL-positive MRSA
isolates from nasal carriers belonged to clonal
complex CC80 (ST80). Two additional isolates
were of the ST377 type. Six tst-positive MRSA
isolates from patients and one tst-negative isolate
from an uninfected child belonged to ST30
(CC30), whereas the unique hospital-associated
strain belonged to ST239 (CC8). The antibiotic
resistance proﬁles of 110 MRSA isolates were
clone-related. All CC80 isolates (100) were resis-
tant to kanamycin and fusidic acid, six were also
resistant to erythromycin, and three of the latter
were additionally resistant to clindamycin. ST377
strains (two) were resistant to kanamycin, tobra-
mycin and gentamicin. CC30 isolates (seven) were
resistant only to b-lactams, whereas the single
CC8 isolate was resistant to kanamycin, gentami-
cin, erythromycin, clindamycin, ciproﬂoxacin,
fusidic acid and sulphamethoxazole–trimetho-
prim. Among MSSA isolates (64), 17 PFGE types
were identiﬁed, including type A, which was also
detected among MRSA. Eleven MSSA isolates
were resistant to erythromycin, of which six were
also resistant to clindamycin, two were also
resistant to gentamicin, and three were also
resistant to fusidic acid. Six of ten clindamycin-
resistant isolates showed inducible resistance.
Fifty-four of 64 MSSA isolates (84%) and 102 of
106 MRSA isolates (96%) produced b-lactamase
(p 0.0149).
Ninety-nine of 106 MRSA isolates from the
studied patients carried the PVL genes, exhibiting
a statistically signiﬁcant difference as compared
to MSSA isolates (93% vs. 17%, p <0.0001)
(Table 3). However, MSSA isolates carried, at
higher frequencies, genes of the superantigen
family (tst, seg, sem) (Table 3). The presence of
PVL was associated with six MSSA clones,
whereas tst was associated with seven clones,
including PFGE type A (CC30), which was also
detected among tst-positive MRSA isolates.
S. aureus isolates from uninfected children carried
seg at a higher frequency (Table 3). No S. aureus
isolates carried exfoliative toxin genes.
The presence of PVL in clinical isolates was
strongly correlated with SSTIs (81 ⁄ 96 or 84.4% vs.
39.2%, p <0.001), whereas the presence of super-
antigen genes, mainly tst, was correlated with
invasive infections (13 ⁄ 74 or 17.6% vs. 4.2%,
p 0.0085). The combined presence of sem ⁄ seg, as
Table 2. Molecular characterization of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from the studied
patients and nasal carriers
MRSA PFGE ⁄ agr a MLST (CC): number of strains PVL tst sem seg
Studied patients (n = 106) SSTIs (n = 75) C ⁄ 3 ST80 (CC80): 71 71 – 1 4
A ⁄ 3 ST30 (CC30): 2 – 2 2 2
G ⁄ 1 ST377: 1 1 – – –
E ⁄ 1 ST239 (CC8): 1 – – 1 –
Deep-seated infections (n = 31) C ⁄ 3 ST80 (CC80): 26 26 – 2 –
A ⁄ 3 ST30 (CC30): 4 – 4 2 2
G ⁄ 1 ST377: 1 1 – – –
Total patients 106 99 6 8 8
Nasal carriers (n = 4) C ⁄ 3 ST80 (CC80): 3 3 – – –
A ⁄ 3 ST30 (CC30): 1 – – 1 1
SSTIs, skin and soft-tissue infections; PFGE, pulsed-ﬁeld gel electrophoresis; MLST (CC), multilocus sequence types and clonal complexes.
aPFGE ⁄ agr: Clones deﬁned by PFGE and agr types.
Table 3. Comparative gene content in Staphylococcus aureus isolates from patients and nasal carriers
Gene
Patients Total patients (n = 170), n (%) S. aureus nasal carriers (n = 73), n (%)
p-valuea
MRSA
(total n = 106),
n (%)
MSSA
(total n = 64),
n (%) p-valuea
mecA 106 – – 106 (62.3) 4 (5.5) <0.0001
PVL 99 (93.4) 11 (17.2) <0.0001 110 (64.7) 6 (8.2) <0.0001
tst 6 (5.7) 11 (17.2) 0.0305 17 (10.0) 11 (15.0) 0.3596
sem 8 (7.5) 33 (51.6) <0.0001 41 (24.1) 17 (23.3) >0.999
seg 8 (7.5) 37 (57.8) <0.0001 45 (26.5) 38 (52.0) 0.0002
sem and seg 5 (4.7) 29 (45.3) <0.0001 34 (20.0) 17 (23.3) 0.6849
sem or seg 11 (10.4) 41 (64.0) <0.0001 52 (30.6) 38 (52.0) 0.0024
PVL and sem and seg 1 (0.94) 6 (9.4) 0.0225 7 (4.1) 1 (1.4) 0.4777
MRSA, methicillin-resistant S. aureus; MSSA, methicillin-sensitive S. aureus; PVL, Panton–Valentine leukocidin.
aChi-squared test.
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well as PVL ⁄ sem ⁄ seg, between the groups was
statistically insigniﬁcant. Treatment was per-
formed according to antibiotic susceptibility tests.
Patients with invasive infections received intra-
venous therapy, whereas most SSTI patients were
treated by mouth. Surgical intervention was
undertaken for all patients with abscesses, septic
arthritis, deep-seated wound infections, pyomyo-
sitis, and boils, as well as in 12 cases of osteomy-
elitis. All patients recovered after treatment.
Characteristics of uninfected children
Among the 123 uninfected children (71 boys and
52 girls, median age 54 months, IQR 14–
120 months), 73 were nasal S. aureus carriers
(59%). Four isolates were MRSA (5.5%), of which
three carried PVL genes. The same genes were
found in only three of the remaining 69 MSSA
isolates (p <0.0001). The presence of superantigen
genes was statistically insigniﬁcant (p >0.05).
DISCUSSION
A marked increase in S. aureus infections among
children, especially those due to CA-MRSA, is
demonstrated in the present study. With the
exception of one case of hospital-associatedMRSA,
all cases in the study were community-associated.
Identiﬁcation of MRSA is no longer limited to
previous hospitalization or predisposing risk fac-
tors [2,3,9]. In western Greece, total MRSA infec-
tions involving both children and adults have
increased, and were calculated to be 45% and 49%
during 2005 and 2006, respectively. Among chil-
dren, MRSA constituted 53% and 71% of total
S. aureus infections during 2005 and 2006, respec-
tively. This phenomenonmay be due to an increase
in MRSA colonization among children, and is in
agreement with ﬁndings of other investigators,
who have identiﬁed higher rates of CA-MRSA
among children than among adults (69.8% vs.
58.5%) [27]. In this study, children <5 years of age
have more than a two-fold increased risk of MRSA
infection as compared to older children
(OR = 2.26). The predominance of staphylococcal
infections in boys has not as yet been explained.
The monthly distribution of S. aureus infections
during two consecutive years showed a pro-
nounced increase during the hot season. MRSA
nasal carriage and cases of osteomyelitis involving
increased rates of hospital admission in late sum-
mer and autumn have been reported among
Japanese children [28,29].
The most frequent site of S. aureus colonization
is the anterior nares, although it can be found
elsewhere on the body [8]. Usually, nasal carriage
is high in newborns, showing a gradual reduction
with age [8]. A relationship between S. aureus
nasal carriage and infection was proved by
genotypic analyses of isolated strains [8]. The
high percentage (59%) of S. aureus nasal carriers
in the present study, including 5.5% of MRSA
carriers, correlates with the younger age of unin-
fected children. In a study performed among
healthy Japanese children, 28.2% were nasal
S. aureus carriers, of whom 4.3% were colonized
by PVL-negative MRSA [28].
SSTIs constituted the majority of MRSA cases
among studied patients. However, pneumonia,
bacteraemia, osteomyelitis, deep-seated wound
infections and abscesses were also identiﬁed to a
lesser extent, as similarly reported elsewhere
[2,3,12]. Invasive infections were mainly associ-
ated with MSSA isolates. This is in agreement
with a study among children in Taiwan, where
CA-MSSA isolates were three times more likely to
be associated with invasive infections [6]. MRSA
infections do not differ in severity or outcome
from those caused by MSSA, and it has not yet
been proved unequivocally that they are more
virulent than those caused by MSSA [30]. In the
present study, MSSA isolates mostly carried
genes of the superantigen family (tst, sem, seg)
that were not clone-related. A high percentage of
superantigen gene carriage was observed in
previous studies, even among nasal S. aureus
isolates (57% for seg and 11% for tst) [23]. Even
though no case of toxic shock syndrome was
diagnosed among the studied patients, carriage of
superantigen genes, combined with predomi-
nance of invasive infections, poses the likelihood
of more severe clinical manifestations among
MSSA-infected children.
Molecular analysis revealed a relatively high
percentage of PVL-positive MSSA isolates (17%)
distributed among different clones, as compared
to other studies (6.7% of consecutive MSSA
isolates) [14]. Taken together, these results may
lead to the conclusion that horizontal transfer of
lukS-PV and lukF-PV is continuous in the S. aureus
population, as they are phage-borne [2,3]. On the
other hand, a predominance of PVL-positive
isolates was observed among MRSA (93%). More
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speciﬁcally, 97 of 99 isolates belonged to the
European clone CC80, which has already spread
in Greece and other European countries
[2,3,11,15]. The three PVL-positive MRSA isolates
from carriers also belonged to CC80, providing a
possible source for future endogenous infections
or intrafamilial spread of such strains. Clonal
spread was also shown in a study performed
among 446 children in Philadelphia, with a
notable increase in CA-MRSA, the majority of
isolates belonging to a common PVL gene-
positive clone [31]. Classiﬁcation of the remaining
two PVL gene-positive MRSA isolates as mem-
bers of ST377, a clone recently identiﬁed in France
and Greece [12,13], reinforces the possibility of
parallel horizontal gene transfer. The statistically
signiﬁcant differences concerning WBCs and
PMNs among MRSA-infected patients, as com-
pared to those infected with MSSA, may be due to
the predominance of PVL-producing isolates in
this bacterial population. We have recently shown
that osteomyelitis cases were caused by PVL
gene-positive S. aureus strains [15].
The paediatric population studied was treated
by mouth or intravenously, with or without
surgical intervention, according to the severity
of infection and the antibiotic susceptibility
pattern of the isolated strain. CA-MRSA isolates
express heterogeneous resistance to oxacillin,
with lower MICs of the antibiotic, which accounts
for improvement after treatment with b-lactams
[6]. Since the lately encountered spread of CA-
MRSA in Greece, most physicians re-adjust treat-
ment according to antibiotic susceptibility tests,
despite the low MICs of oxacillin. Vancomycin is
reserved for severe hospital-acquired infections,
whereas erythromycin, clindamycin and sulpha-
methoxazole–trimethoprim are suitable oral anti-
biotics for MRSA infections, as reported
elsewhere [27,32].
In the present study, a seasonal distribution of
staphylococcal infections was shown, with an
increasing incidence of CA-MRSA among youn-
ger children, implying that this may be due
mainly to clonal spread of PVL-positive isolates.
The genotypes of MRSA clones identiﬁed in
S. aureus from nasal carriers correlated well
with those of patient isolates. The majority of
CA-MSSA isolates were associated with invasive
infections, and carried predominantly genes of
the superantigen family. Successful treatment
of S. aureus infections in children requires
epidemiological data for the country, in combi-
nation with information on genetic proﬁles and
antibiotic susceptibility patterns.
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